<DOC>
	<DOCNO>NCT00346827</DOCNO>
	<brief_summary>To determine safety tolerability repeat dose Apomorphine Nasal Powder subject Parkinson 's Disease .</brief_summary>
	<brief_title>Apomorphine Nasal Powder Treatment Parkinson 's Disease `` Off '' Periods .</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Apomorphine</mesh_term>
	<criteria>1 year history Parkinson 's Disease ; stable PD medication 4 week ; least one document `` '' period per day hypersensitivity apomorphine ; participation clinical trial last 12 week ; pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2006</verification_date>
</DOC>